MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 10 - per page
Order by
Inventors have shown that, in human patients, the administration of anti-muscarinic agents produces a rapid, prolonged alleviation of depressive symptoms. More
Use of new bufadienolide derivatives were synthesized. These steroids have showed to affect cell growth, induce apoptosis and provoke unique changes in intracellular membrane traffic and endosomal pH. Of particular interest are the observations... More
A series of substituted 3,6-diphenyl-7H-[1,2,4] triazolo[3,4-b] [1,3,4] thiadiazines that act as inhibitors of PDE4 More
Recent advances in pharmacology, molecular biology, and genetics on the serotonin system hold out the promise of the development of improved pharmacological treatment for some aspects of neurological diseases. More
Lead Inventor: Koji Nakanishi Problem or Unmet Need: Ginkgo biloba is a frequently used herbal remedy for increasing cognitive function in the elderly and Alzheimer's patients, treating vascular and neurodegenerative dementia, and improving circulation... More
Lead Inventor: Michael Terman Problem or Unmet Need: It is estimated that about 10 million Americans suffer from winter depression at a fully syndromal level, with another 25 million suffering at a milder subsyndromal level which is less debilitating and. More
Displaying 1..10 of 10 - per page
Order by

Your selection

Therapeutic target
Central Nervous System del
Psychiatric del
Depression del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
Need competitive intelligence information
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us